Cargando…
Renoprotective effect of chronic treatment with sodium-glucose cotransporter 2 inhibitors and its associated factors in Japanese patients with chronic heart failure and diabetes
BACKGROUND: Recent clinical trials have shown that sodium-glucose cotransporter 2 (SGLT2) inhibitors have beneficial effects on renal function in heart failure patients. This study confirmed the renoprotective effect of treatment with SGLT2 inhibitors in Japanese patients with chronic heart failure...
Autores principales: | Yokouchi, Go, Horio, Takeshi, Matsumoto, Naoki, Fukuda, Kohei, Yoshimura, Ryutaro, Fujiwara, Ryosuke, Matsuoka, Yujiro, Sakamoto, Yuya, Iwashima, Yoshio, Oshiro, Yoshiyuki, Fujimoto, Kohei, Kasayuki, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706163/ https://www.ncbi.nlm.nih.gov/pubmed/36457725 http://dx.doi.org/10.1016/j.ijcha.2022.101152 |
Ejemplares similares
-
The Anticipated Renoprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors
por: Ito, Marie, et al.
Publicado: (2018) -
Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection
por: Haruhara, Kotaro, et al.
Publicado: (2022) -
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
por: Kim, Nam Hoon, et al.
Publicado: (2022) -
Ankle‐brachial index, arterial stiffness, and biomarkers in the prediction of mortality and outcomes in patients with end‐stage kidney disease
por: Otsuka, Kenichiro, et al.
Publicado: (2019) -
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
por: Takata, Tomoaki, et al.
Publicado: (2021)